Brimonidine Tartrate

Product NDC
25021-003
Requested package NDC
25021-003-05
11-digit product format
250210003
Labeler code
25021
Product ID
25021-003_5f587723-8395-4bff-8846-baf8413cd08d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Brimonidine Tartrate
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Labeler
Sagent Pharmaceuticals
Application
ANDA219219
Marketing category
ANDA
Marketing start
2026-11-15
Substance
BRIMONIDINE TARTRATE
Active strength
1 mg/mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219219-001BRIMONIDINE TARTRATEBRIMONIDINE TARTRATE0.1%SOLUTION/DROPS / OPHTHALMICAB2026-03-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A219219-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A219219-001BRIMONIDINE TARTRATE0.1%SOLUTION/DROPS / OPHTHALMICAB2026-03-11d4dbc9d85df4…
2026-10-15 13:18:302026-09A219219-001BRIMONIDINE TARTRATE0.1%SOLUTION/DROPS / OPHTHALMICAB2026-03-11c2088c7a36db…
2026-09-14 22:38:342026-08A219219-001BRIMONIDINE TARTRATE0.1%SOLUTION/DROPS / OPHTHALMICAB2026-03-1184e616aacf4f…
2026-08-18 06:07:402026-07A219219-001BRIMONIDINE TARTRATE0.1%SOLUTION/DROPS / OPHTHALMICAB2026-03-11caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219219-001BRIMONIDINE TARTRATE0.1%SOLUTION/DROPS / OPHTHALMICAB2026-03-11a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A219219-001AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A219219-001AB1c2088c7a36db…
2026-09-14 22:38:342026-08A219219-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A219219-001AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219219-001AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Brimonidine TartrateBRIMONIDINE TARTRATEGland Pharma Limitede4b04ef1-6586-4386-a844-2c5fc3bd4a8f2026-03-12Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219219
application number: ANDA219219

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
25021-003-05250210003051 BOTTLE, DROPPER in 1 CARTON (25021-003-05) / 5 mL in 1 BOTTLE, DROPPER2026-11-15NoNoHistorical